Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
Titel:
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
Auteur:
Liva, Sophia Chen, Min Mortazavi, Amir Walker, Alison Wang, Jiang Dittmar, Kristin Hofmeister, Craig Coss, Christopher C. Phelps, Mitch A.
Verschenen in:
European journal of drug metabolism and pharmacokinetics